Built SkyBridge Capital into an alternatives platform known for hedge fund seeding, macro hedge fund allocations and the SALT investor conference, and later expanded into digital assets and advisory services to institutional and wealthy private clients. Anthony Scaramucci holds degrees from Tufts and Harvard (JD/MBA), launched a Wall Street career in investment banking and asset management, briefly served in a senior White House communications role, and remains an active commentator and deal-maker focused on capital markets, fundraising and alternative investment distribution.
Built SkyBridge Capital into an alternatives platform known for hedge fund seeding, macro hedge fund allocations and the SALT investor conference, and later expanded into digital assets and advisory services to institutional and wealthy private clients. Anthony Scaramucci holds degrees from Tufts and Harvard (JD/MBA), launched a Wall Street career in investment banking and asset management, briefly served in a senior White House communications role, and remains an active commentator and deal-maker focused on capital markets, fundraising and alternative investment distribution.
Combines opportunistic macro and alternatives-oriented investing with a distribution and capital-raising bias, favoring event-driven, macro and digital-asset strategies where promoter/placement advantages amplify returns. Emphasizes seeding high-conviction hedge managers, active portfolio construction across liquid and illiquid alternatives, and leveraging media and networks to source deal flow. Time horizon ranges from tactical macro cycles to multi-year manager commitments; risk discipline centers on manager selection, concentrated conviction bets, and liquidity management.
Combines opportunistic macro and alternatives-oriented investing with a distribution and capital-raising bias, favoring event-driven, macro and digital-asset strategies where promoter/placement advantages amplify returns. Emphasizes seeding high-conviction hedge managers, active portfolio construction across liquid and illiquid alternatives, and leveraging media and networks to source deal flow. Time horizon ranges from tactical macro cycles to multi-year manager commitments; risk discipline centers on manager selection, concentrated conviction bets, and liquidity management.
| Trades 5745 | Longs Won 2457/5745 42% | Profit Factor 1.44 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $7.58M |
| Average Win $2.32M | Best Trade (Jun 30) $203.8M | Sharpe Ratio -20.07 |
| Average Loss -$1.21M | Worst Trade (Sep 30) -$435.27M | Z-Score -1.94 (97.4%) |
| Commissions $0 | Avg. Trade Length 9m 2d | Expectancy $302,637.18 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% | 1.43% |
| Consecutive Losing Trades | 3,175 | 2,857 | 2,540 | 2,222 | 1,905 | 1,587 | 1,270 | 952 | 635 | 317 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 11,982 | $1.59M | $1.78M | - | $188,392.93 | 11.84% | -0.494% |
ABNB Airbnb, Inc. | 74,687 | $10.58M | $13.75M | - | $3.17M | 29.99% | -0.578% |
ABT Abbott Laboratories | 22,381 | $2.03M | $2.49M | - | $458,922.34 | 22.6% | -0.022% |
AFL Aflac Inc. | 6,378 | $747,821 | $774,671.88 | - | $26,850.88 | 3.59% | +0.297% |
AGIO Agios Pharmaceuticals Inc. | 2.4M | $66.87M | $80.54M | - | $13.68M | 20.45% | +0.269% |
AHR American Healthcare REIT, Inc. | 4,424 | $230,712 | $240,267.44 | - | $9,555.44 | 4.14% | +1.325% |
AJG Arthur J. Gallagher & Co. | 1,113 | $255,511 | $279,596.74 | - | $24,085.74 | 9.43% | -0.899% |
ALAB ASTERA LABS INC COMMON STOCK (Ticker: 1ALAB) | 6,323 | $3.05M | $2.03M | - | -$1.02M | -33.4% | -0.341% |
ALBT Avalon Globocare Corp | 122,576 | $35,670 | $26,770.6 | - | -$8,899.4 | -24.95% | -4.253% |
ALGN Align Technology, Inc. | 180,286 | $29.68M | $32.67M | - | $2.99M | 10.06% | +2.835% |
AMAT Applied Materials, Inc. | 7,084 | $2.42M | $3.59M | - | $1.17M | 48.37% | -5.132% |
AMZN Amazon.com Inc | 284,562 | $61.23M | $74.74M | - | $13.51M | 22.06% | -0.932% |
ANGO Angiodynamics Inc. | 2.2M | $21.95M | $34.84M | - | $12.88M | 58.68% | +1.213% |
ANRO Alto Neuroscience Inc. | 864,000 | $1.89M | $27.77M | - | $25.88M | 1,369.63% | -0.495% |
AOS A. O. Smith Corporation | 3,243 | $203,401 | $201,617.31 | - | -$1,783.69 | -0.88% | -0.528% |
APA APA Corporation | 9,521 | $310,099 | $385,362.47 | - | $75,263.47 | 24.27% | +1.188% |
APP AppLovin Corporation Class A Common Stock | 28,228 | $11.86M | $8.9M | - | -$2.96M | -24.92% | +0.873% |
APPN Appian Corporation | 300,000 | $6.87M | $10.62M | - | $3.75M | 54.63% | -4.323% |
ARAY Accuray Incorporated | 5.74M | $7.24M | $1.61M | - | -$5.63M | -77.81% | 0.0 |
ARCC Ares Capital Corporation | 14,191 | $262,959 | $281,975.17 | - | $19,016.17 | 7.23% | -1.585% |